Bruna, J., Videla, S., Argyriou, A. A., Velasco, R., Villoria, J., Santos, C., . . . Plata Salamán, C. (2017). Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial.
Citación estilo ChicagoBruna, Jordi, et al. Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial. 2017.
Cita MLABruna, Jordi, et al. Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial. 2017.
Precaución: Estas citas no son 100% exactas.